Ekso Bionics Holdings, Inc. (EKSO) News

Ekso Bionics Holdings, Inc. (EKSO): $0.89

0.03 (+3.63%)

POWR Rating

Component Grades

Momentum

D

Stability

C

Sentiment

Quality

D

Filter EKSO News Items

EKSO News Results

Date Symbol Company Title Start End Change POWR Rating
Loading, please wait...

EKSO News Highlights

  • EKSO's 30 day story count now stands at 2.
  • Over the past 26 days, the trend for EKSO's stories per day has been choppy and unclear. It has oscillated between 1 and 1.
  • CMS, CM and NOV are the most mentioned tickers in articles about EKSO.

Latest EKSO News From Around the Web

Below are the latest news stories about EKSO BIONICS HOLDINGS INC that investors may wish to consider to help them evaluate EKSO as an investment opportunity.

Ekso Bionics Receives CMS Coding Approval for Ekso Indego Personal

SAN RAFAEL, Calif., Dec. 12, 2023 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the “Company”), an industry leader in exoskeleton technology for medical and industrial use, today announced that the Pricing, Data Analysis, and Coding (“PDAC”) contractor for the Centers for Medicare & Medicaid Services (“CMS”) has completed its review of the Ekso Indego Personal and approved use of Healthcare Common Procedure Coding System (“HCPCS”) Code K1007 to bill Medicare for such device. CM

Yahoo | December 12, 2023

Ekso Bionics to Participate at Centers for Medicare & Medicaid Services (CMS) Second Biannual 2023 Healthcare Common Procedure Coding System (HCPCS) Public Meeting on Wednesday, November 29

SAN RAFAEL, Calif., Nov. 16, 2023 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the “Company”), an industry leader in exoskeleton technology for medical and industrial use, today announced that the Company will participate at the Centers for Medicare & Medicaid Services’ (“CMS”) Healthcare Common Procedure Coding System (“HCPCS”) public meeting on November 29, 2023, to discuss appropriate Medicare payment for the Ekso Indego Personal. “We appreciate CMS for providing Ekso with

Yahoo | November 16, 2023

Centers for Medicare & Medicaid Services (CMS) Codifies Medicare Coverage for Ekso Indego Personal

Ruling Could Significantly Expand Use of Ekso Indego Personal in Home and Community Markets SAN RAFAEL, Calif., Nov. 02, 2023 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the “Company”), an industry leader in exoskeleton technology for medical and industrial use, announces that the Centers for Medicare & Medicaid Services (“CMS”) finalized its Calendar Year 2024 Home Health Prospective Payment System Rule CMS-1780 (“2024 Home Health Rule”), which includes exoskeletons in the M

Yahoo | November 2, 2023

Ekso Bionics Holdings, Inc. (NASDAQ:EKSO) Q3 2023 Earnings Call Transcript

Ekso Bionics Holdings, Inc. (NASDAQ:EKSO) Q3 2023 Earnings Call Transcript October 26, 2023 Ekso Bionics Holdings, Inc. beats earnings expectations. Reported EPS is $-0.24, expectations were $-0.31. Operator: Greetings, and welcome to the Ekso Bionics Quarter Three 2023 Financial Results Call. At this time all participants are in a listen-only mode. A brief question-and-answer session […]

Yahoo | October 27, 2023

Q3 2023 Ekso Bionics Holdings Inc Earnings Call

Q3 2023 Ekso Bionics Holdings Inc Earnings Call

Yahoo | October 27, 2023

Ekso Bionics Reports Third Quarter 2023 Revenue Growth of 38%

Achieves Record Quarter of EVO Unit SalesSAN RAFAEL, Calif., Oct. 26, 2023 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the “Company”), an industry leader in exoskeleton technology for medical and industrial use, today reported financial results for the three and nine months ended September 30, 2023. Recent Highlights and Accomplishments Reported revenue of $4.6 million in the third quarter of 2023, an increase of 38% year-over-yearSold a total of 41 EksoHealth devices in the

Yahoo | October 26, 2023

Ekso Bionics to Report Third Quarter 2023 Financial Results on October 26, 2023

SAN RAFAEL, Calif., Oct. 19, 2023 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the “Company”), an industry leader in exoskeleton technology for medical and industrial use, today announced that it will release financial and business results for the third quarter 2023 after the close of trading on Thursday, October 26, 2023. Management will host a conference call beginning at 1:30 p.m. PT / 4:30 p.m. ET to discuss the financial results and recent business developments. A live we

Yahoo | October 19, 2023

Ekso Bionics Supports Centers for Medicare & Medicaid Services (CMS) Proposed Rule to Include Personal Exoskeletons within a Medicare Benefit Category

SAN RAFAEL, Calif., Sept. 27, 2023 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the “Company”), an industry leader in exoskeleton technology for medical and industrial use, supports the Centers for Medicare & Medicaid Services (“CMS”) proposal to include personal exoskeletons in the Medicare benefit category for braces in the updated 2024 Home Health Prospective Payment System Rate. “This newly proposed rule is highly relevant for our business and individuals with a spinal cor

Yahoo | September 27, 2023

Q2 2023 Ekso Bionics Holdings Inc Earnings Call

Q2 2023 Ekso Bionics Holdings Inc Earnings Call

Yahoo | July 28, 2023

Ekso Bionics (EKSO) Reports Q2 Loss, Tops Revenue Estimates

Ekso Bionics (EKSO) delivered earnings and revenue surprises of -10.71% and 8.12%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?

Yahoo | July 27, 2023


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!